ATC Group: A02BA02 Ranitidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BA02 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
H2-receptor antagonists
5
A02BA02
Ranitidine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.3 g
PAREN - Parenteral
0.3 g

Active ingredients in A02BA02

Active Ingredient
Description

Ranitidine is a specific rapidly acting histamine H2-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion. Ranitidine has a relatively long duration of action and so a single 150 mg dose effectively suppresses gastric acid secretion for twelve hours.

Medicines in this ATC group

Drug
Countries

Singapore

Hong Kong

Brazil

Cyprus Estonia

Australia

South Africa

South Africa

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Singapore

South Africa

United Kingdom

Hong Kong

Singapore

South Africa

Hong Kong Singapore

Brazil

Cyprus Singapore

Lithuania

Brazil

Hong Kong

New Zealand

Hong Kong

Hong Kong

Singapore

South Africa

Estonia Lithuania Poland

Poland

United Kingdom

Hong Kong

Lithuania Poland

South Africa

South Africa

Cyprus Hong Kong

Estonia Lithuania Poland

Lithuania

South Africa

South Africa

Hong Kong

Tunisia

Hong Kong

Hong Kong

Poland

Tunisia

Hong Kong

Hong Kong

Singapore

South Africa

South Africa

Hong Kong

Hong Kong

Singapore

Hong Kong

Singapore

Australia Canada Cyprus Estonia Hong Kong ...

Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK